Affordable Access

Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.

Authors
  • Fordy, C
  • Glover, C
  • Davies, M M
  • Allen-Mersh, T G
Type
Published Article
Journal
British journal of cancer
Publication Date
Oct 01, 1998
Volume
78
Issue
8
Pages
1058–1060
Identifiers
PMID: 9792150
Source
Medline
License
Unknown

Abstract

Hepatic arterial floxuridine (HAI) in 35 patients with systemic fluorouracil/folinic acid-resistant colorectal liver metastases achieved a 14% partial response and 26% disease stabilization rate, with a median response duration of 7 months from onset of HAI.

Report this publication

Statistics

Seen <100 times